Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
CLINICAL AND EXPERIMENTAL ALLERGY(2024)
关键词
biologic agents,eosinophils,mepolizumab,omalizumab,real world,severe asthma,switching
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要